Abstract
Abstract Ribonuclease P (RNase P) was first described in the 1970’s as an endoribonuclease in the maturation of precursor transfer RNAs (tRNAs). More recent studies, however, have uncovered non-canonical roles for RNase P and its components. Here, we review the recent progress of its involvement in chromatin assembly, DNA damage response, and maintenance of genome stability with implications in tumorigenesis. The possibility of RNase P as a therapeutic target in cancer is also discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have